Jump to content

C-Met Positive/Crizotinib

Deb B

Recommended Posts

Is c-met positive the same as ALK?  They both can be treated with Crizotinib.  Does Crizotinib kill the cancer or just keep it stable with the TLK inhibitors?

Link to comment
Share on other sites


To the best of my knowledge c-MET and ALK are completely different.  Anaplastic lymphoma kinase (ALK) rearrangement is an unusual genetic rearrangement.  C-MET is a genetic signaling pathway involving the spreading, migration and invasion of cancer cells. Now that is my synthesis of some very complicated journal articles.  But, I believe I understand enough to conclude that ALK and c-MET are not similar processes or mutations.

Crizotinib is a targeted therapy used for adenocarcinoma that displays ALK rearrangement. It also is effective for those that display c-MET biomarkers.  My reading of several journal articles suggests Crizotnib destroys the tumor.

But I am not a doctor and I could be wrong.  Some of these journal articles are very hard to comprehend so you might want to tee this question up to your medical oncologist.

Stay the course.


Link to comment
Share on other sites


This topic is now archived and is closed to further replies.

  • Create New...

Important Information

By using this site, you agree to our Terms of Use.